NICE recommends new treatment for constipation
The National Institute for Health and Care Excellence has issued final draft guidance recommending naloxegol for constipation. Naloxegol (Moventig; AstraZeneca) is recommended as an option for treating opioid-induced constipation in adults whose symptoms have not adequately responded to laxatives.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068639
Recommended from Pharmaceutical Press